Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HOXA10 SOX11 TCF4 JUNB JUND HOXB7 GATA4 SRF TLX1	7.95e-05	560	65	9	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HOXA10 SOX11 TCF4 JUNB JUND HOXB7 GATA4 SRF TLX1	8.62e-05	566	65	9	GO:0001216
GeneOntologyMolecularFunction	receptor signaling protein tyrosine kinase activator activity	LTK ALK	1.04e-04	5	65	2	GO:0030298
GeneOntologyMolecularFunction	NFAT protein binding	GATA4 GATA6	1.55e-04	6	65	2	GO:0051525
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	HOXA10 SOX11 TCF4 JUNB JUND HOXB7 GATA4 SRF GATA6 GATA5 SUZ12 TLX1	6.02e-04	1244	65	12	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	HOXA10 SOX11 TCF4 JUNB JUND HOXB7 GATA4 SRF GATA6 GATA5 SUZ12 TLX1	7.29e-04	1271	65	12	GO:0000987
GeneOntologyMolecularFunction	potassium ion binding	ACAT1 CPS1	9.26e-04	14	65	2	GO:0030955
GeneOntologyMolecularFunction	transcription coregulator binding	JUND GATA4 GATA6 SUZ12	1.13e-03	140	65	4	GO:0001221
GeneOntologyBiologicalProcess	digestive tract development	SOX11 NPHP3 GATA4 DCHS1 GATA6 GATA5 CPS1	5.00e-07	152	65	7	GO:0048565
GeneOntologyBiologicalProcess	digestive system development	SOX11 NPHP3 GATA4 DCHS1 GATA6 GATA5 CPS1	9.43e-07	167	65	7	GO:0055123
GeneOntologyBiologicalProcess	heart morphogenesis	SOX11 NPHP3 GATA4 SRF DCHS1 GATA6 GATA5	6.65e-05	321	65	7	GO:0003007
GeneOntologyBiologicalProcess	striated muscle adaptation	LMNA GATA4 GATA6 ACTN3	8.30e-05	73	65	4	GO:0014888
GeneOntologyBiologicalProcess	tube development	SOX11 TCF4 JUNB HOXB7 NPHP3 RASA1 ACAT1 MTHFD1L GATA4 SRF DCHS1 GATA6 GATA5 CPS1	9.66e-05	1402	65	14	GO:0035295
GeneOntologyBiologicalProcess	mitral valve formation	GATA4 DCHS1	9.72e-05	5	65	2	GO:0003192
GeneOntologyBiologicalProcess	tissue morphogenesis	SOX11 HOXB7 NPHP3 MTHFD1L GATA4 SRF DCHS1 GATA5 EYA2 FLG2	1.12e-04	750	65	10	GO:0048729
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell apoptotic process	GATA4 GATA6 LTK RGL2	1.43e-04	84	65	4	GO:0010665
GeneOntologyBiologicalProcess	epithelium development	SOX11 HOXB7 NPHP3 ACAT1 MTHFD1L KRT84 KRT77 GATA4 SRF DCHS1 GATA6 GATA5 CPS1 FLG2	1.58e-04	1469	65	14	GO:0060429
GeneOntologyBiologicalProcess	intestinal epithelial cell differentiation	GATA4 GATA6 GATA5	1.67e-04	34	65	3	GO:0060575
GeneOntologyBiologicalProcess	muscle adaptation	LMNA GATA4 GATA6 GATA5 ACTN3	1.68e-04	164	65	5	GO:0043500
GeneOntologyBiologicalProcess	regulation of striated muscle cell apoptotic process	GATA4 GATA6 LTK RGL2	1.72e-04	88	65	4	GO:0010662
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	CACNA1A SOX11 TCF4 JUNB MTHFD1L GATA4 SRF DCHS1 GATA6 AGFG1 GATA5 EYA2 PTPN18 TLX1	1.75e-04	1483	65	14	GO:0048646
GeneOntologyBiologicalProcess	cardiac muscle cell apoptotic process	GATA4 GATA6 LTK RGL2	1.87e-04	90	65	4	GO:0010659
GeneOntologyBiologicalProcess	striated muscle cell apoptotic process	GATA4 GATA6 LTK RGL2	2.21e-04	94	65	4	GO:0010658
GeneOntologyBiologicalProcess	muscle hypertrophy in response to stress	LMNA GATA4 GATA6	3.14e-04	42	65	3	GO:0003299
GeneOntologyBiologicalProcess	positive regulation of BMP signaling pathway	SOX11 GATA4 GATA6	3.14e-04	42	65	3	GO:0030513
GeneOntologyBiologicalProcess	cardiac muscle hypertrophy in response to stress	LMNA GATA4 GATA6	3.14e-04	42	65	3	GO:0014898
GeneOntologyBiologicalProcess	cardiac muscle adaptation	LMNA GATA4 GATA6	3.37e-04	43	65	3	GO:0014887
GeneOntologyBiologicalProcess	atrioventricular node development	GATA4 GATA6	3.47e-04	9	65	2	GO:0003162
GeneOntologyBiologicalProcess	atrioventricular valve formation	GATA4 DCHS1	3.47e-04	9	65	2	GO:0003190
GeneOntologyBiologicalProcess	muscle tissue development	SOX11 LMNA GATA4 SRF GATA6 GATA5 ACTN3 EYA2	3.55e-04	558	65	8	GO:0060537
GeneOntologyBiologicalProcess	embryonic morphogenesis	HOXA10 SOX11 HOXB7 NPHP3 MTHFD1L GATA4 SRF GATA6 EYA2	3.79e-04	713	65	9	GO:0048598
GeneOntologyBiologicalProcess	regulation of telomere maintenance	SMG1 TENT4B LMNA CCT4	4.32e-04	112	65	4	GO:0032204
GeneOntologyBiologicalProcess	animal organ morphogenesis	SOX11 HOXB7 NPHP3 MEGF9 MTHFD1L GATA4 SRF DCHS1 GATA6 GATA5 ACTN3 TLX1	5.39e-04	1269	65	12	GO:0009887
GeneOntologyBiologicalProcess	miRNA metabolic process	TENT4B GATA4 SRF GATA6	5.44e-04	119	65	4	GO:0010586
GeneOntologyBiologicalProcess	cardiac chamber development	SOX11 NPHP3 GATA4 SRF GATA6	5.48e-04	212	65	5	GO:0003205
GeneOntologyBiologicalProcess	gastrulation	NPHP3 GATA4 SRF GATA6 EYA2	5.48e-04	212	65	5	GO:0007369
GeneOntologyBiologicalProcess	formation of primary germ layer	GATA4 SRF GATA6 EYA2	6.35e-04	124	65	4	GO:0001704
GeneOntologyCellularComponent	transcription factor AP-1 complex	JUNB JUND	9.76e-05	5	66	2	GO:0035976
GeneOntologyCellularComponent	keratin filament	KRT84 KRT77 KRTAP1-4 KRTAP1-5	2.52e-04	97	66	4	GO:0045095
HumanPheno	Abnormal cheek morphology	SOX11 TCF4 NPHP3 LMNA GNPTAB GATA4 GATA6 FBXO11 GATA5	5.83e-06	282	26	9	HP:0004426
HumanPheno	Preauricular pit	NPHP3 GATA4 GATA6 FBXO11 GATA5	1.13e-05	61	26	5	HP:0004467
HumanPheno	Periauricular skin pits	NPHP3 GATA4 GATA6 FBXO11 GATA5	1.80e-05	67	26	5	HP:0100277
HumanPheno	Branchial anomaly	NPHP3 GATA4 GATA6 FBXO11 GATA5	3.78e-05	78	26	5	HP:0009794
HumanPheno	Heart murmur	GNPTAB GATA4 GATA6 GATA5	3.89e-05	39	26	4	HP:0030148
HumanPheno	Abnormal heart sound	GNPTAB GATA4 GATA6 GATA5	5.23e-05	42	26	4	HP:0031657
HumanPheno	Skin pit	NPHP3 GATA4 GATA6 FBXO11 GATA5	5.42e-05	84	26	5	HP:0100276
HumanPheno	Edema	CACNA1A TCF4 LMNA RASA1 ACAT1 GNPTAB GATA4 DCHS1 GATA6 FBXO11 CPS1 KPTN	6.19e-05	699	26	12	HP:0000969
HumanPheno	Weight loss	TCF4 LMNA ZNRF3 ACAT1 GNPTAB GATA4 FUS ALK VCP	7.64e-05	388	26	9	HP:0001824
HumanPheno	Full cheeks	SOX11 TCF4 LMNA GNPTAB GATA4 FBXO11	8.65e-05	151	26	6	HP:0000293
HumanPheno	Atrial flutter	LMNA GATA4 GATA6	1.48e-04	21	26	3	HP:0004749
HumanPheno	Localized skin lesion	TCF4 NPHP3 LMNA RASA1 ZNRF3 GATA4 DCHS1 GATA6 FBXO11 GATA5 SUZ12 FUS ALK	1.55e-04	897	26	13	HP:0011355
HumanPheno	Orthopnea	LMNA GATA4 GATA6 FUS VCP	1.80e-04	108	26	5	HP:0012764
HumanPheno	Abnormality of fluid regulation	CACNA1A TCF4 LMNA RASA1 ACAT1 GNPTAB GATA4 DCHS1 GATA6 FBXO11 CPS1 KPTN	2.07e-04	789	26	12	HP:0011032
HumanPheno	Dyscalculia	CACNA1A FUS VCP	2.23e-04	24	26	3	HP:0002442
HumanPheno	Underdeveloped supraorbital ridges	SOX11 GATA4 GATA6 GATA5	2.43e-04	62	26	4	HP:0009891
HumanPheno	Pelvic girdle muscle atrophy	LMNA VCP	2.48e-04	5	26	2	HP:0008988
HumanPheno	Aplasia/Hypoplasia of the musculature of the pelvis	LMNA VCP	2.48e-04	5	26	2	HP:0001471
HumanPheno	Abnormality of the supraorbital ridges	SOX11 GATA4 GATA6 GATA5 SUZ12	2.52e-04	116	26	5	HP:0100538
HumanPheno	Cyanosis	TCF4 LMNA GATA4 GATA6 NUP214	2.62e-04	117	26	5	HP:0000961
HumanPheno	Clinodactyly	SOX11 TCF4 LMNA GATA4 DCHS1 GATA6 FBXO11 GATA5 SUZ12 KPTN	3.02e-04	574	26	10	HP:0030084
HumanPheno	Abnormal long bone morphology	TCF4 NPHP3 LMNA RASA1 GNPTAB TRIM8 GATA4 DCHS1 FBXO11 SUZ12 AGPS VCP	3.04e-04	821	26	12	HP:0011314
HumanPheno	Congestive heart failure	TCF4 LMNA RASA1 GNPTAB GATA4 GATA6 VCP	3.58e-04	278	26	7	HP:0001635
HumanPheno	Anterior bulging of the globe	LMNA GNPTAB GATA4 GATA6 FBXO11 GATA5 ALK	4.00e-04	283	26	7	HP:0000644
HumanPheno	Proptosis	LMNA GNPTAB GATA4 GATA6 FBXO11 GATA5 ALK	4.00e-04	283	26	7	HP:0000520
HumanPheno	Abnormal periauricular region morphology	NPHP3 GATA4 GATA6 FBXO11 GATA5	4.44e-04	131	26	5	HP:0000383
Domain	GATA_N	GATA4 GATA6 GATA5	4.21e-08	3	66	3	IPR008013
Domain	GATA-N	GATA4 GATA6 GATA5	4.21e-08	3	66	3	PF05349
Domain	ZnF_GATA	GATA4 GATA6 GATA5	9.06e-06	12	66	3	SM00401
Domain	TF_GATA_4/5/6	GATA4 GATA5	1.23e-05	2	66	2	IPR016375
Domain	Znf_GATA	GATA4 GATA6 GATA5	1.86e-05	15	66	3	IPR000679
Domain	GATA	GATA4 GATA6 GATA5	1.86e-05	15	66	3	PF00320
Domain	GATA_ZN_FINGER_1	GATA4 GATA6 GATA5	2.28e-05	16	66	3	PS00344
Domain	GATA_ZN_FINGER_2	GATA4 GATA6 GATA5	2.28e-05	16	66	3	PS50114
Domain	Jun	JUNB JUND	3.68e-05	3	66	2	PF03957
Domain	JNK	JUNB JUND	3.68e-05	3	66	2	IPR005643
Domain	Leuzip_Jun	JUNB JUND	3.68e-05	3	66	2	IPR002112
Domain	IF	LMNA LZTS3 KRT84 KRT77	1.51e-04	76	66	4	IPR001664
Domain	Tyr_kinase_rcpt_2_CS	LTK ALK	6.63e-04	11	66	2	IPR002011
Domain	RECEPTOR_TYR_KIN_II	LTK ALK	7.93e-04	12	66	2	PS00239
Domain	-	GATA4 GATA6 GATA5	1.08e-03	57	66	3	3.30.50.10
Domain	Znf_NHR/GATA	GATA4 GATA6 GATA5	1.13e-03	58	66	3	IPR013088
Domain	-	JUNB JUND	1.43e-03	16	66	2	1.10.880.10
Domain	Intermediate_filament_CS	LMNA KRT84 KRT77	1.44e-03	63	66	3	IPR018039
Domain	Filament	LMNA KRT84 KRT77	2.03e-03	71	66	3	SM01391
Domain	IF	LMNA KRT84 KRT77	2.11e-03	72	66	3	PS00226
Domain	Filament	LMNA KRT84 KRT77	2.20e-03	73	66	3	PF00038
Domain	Keratin_2_head	KRT84 KRT77	3.23e-03	24	66	2	IPR032444
Domain	Keratin_2_head	KRT84 KRT77	3.23e-03	24	66	2	PF16208
Domain	Keratin_II	KRT84 KRT77	3.78e-03	26	66	2	IPR003054
Domain	Homeobox_metazoa	HOXA10 HOXB7 TLX1	3.98e-03	90	66	3	IPR020479
Domain	Spectrin_repeat	KRT77 ACTN3	4.70e-03	29	66	2	IPR002017
Domain	Spectrin/alpha-actinin	KRT77 ACTN3	5.70e-03	32	66	2	IPR018159
Domain	SPEC	KRT77 ACTN3	5.70e-03	32	66	2	SM00150
Domain	bZIP_1	JUNB JUND	6.41e-03	34	66	2	PF00170
Domain	TF_DNA-bd	JUNB JUND	7.56e-03	37	66	2	IPR008917
Pubmed	Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells.	GATA4 GATA6 GATA5	6.83e-09	3	67	3	16162334
Pubmed	Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation.	GATA4 GATA6 GATA5	6.83e-09	3	67	3	9566909
Pubmed	GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development.	GATA4 GATA6 GATA5	6.83e-09	3	67	3	9119112
Pubmed	Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6.	GATA4 SRF GATA6 GATA5	8.87e-09	13	67	4	12606287
Pubmed	Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors.	GATA4 SRF GATA6	2.73e-08	4	67	3	12530967
Pubmed	Wnt2 is a direct downstream target of GATA6 during early cardiogenesis.	GATA4 GATA6 GATA5	2.73e-08	4	67	3	16621466
Pubmed	BMP-mediated induction of GATA4/5/6 blocks somitic responsiveness to SHH.	GATA4 GATA6 GATA5	2.73e-08	4	67	3	25294942
Pubmed	Human transcription factor protein interaction networks.	HOXA10 PRR12 SMG1 TCF4 JUNB JUND ZNF609 GATA4 GATA6 CCT4 NUP214 TMED10 FLG2 HNRNPH3 TLX1	6.90e-08	1429	67	15	35140242
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	ZNF609 LMNA ACAT1 MTHFD1L KRT84 KRT77 CCT4 FUS FLG2 VCP	1.14e-07	558	67	10	27591049
Pubmed	The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expression.	GATA4 GATA6 GATA5	1.36e-07	6	67	3	15539431
Pubmed	SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.	HOXB7 GATA4 SRF GATA6	2.13e-07	27	67	4	20417598
Pubmed	Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element.	GATA4 GATA6 GATA5	2.38e-07	7	67	3	15987774
Pubmed	GATA factors and androgen receptor collaborate to transcriptionally activate the Rhox5 homeobox gene in Sertoli cells.	GATA4 GATA6 GATA5	2.38e-07	7	67	3	18212046
Pubmed	Gata6 restricts Isl1 to the posterior of nascent hindlimb buds through Isl1 cis-regulatory modules.	GATA4 GATA6 GATA5	3.80e-07	8	67	3	29197504
Pubmed	The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer.	GATA4 GATA6 GATA5	3.80e-07	8	67	3	14662776
Pubmed	Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo.	GATA4 GATA6 GATA5	5.69e-07	9	67	3	9738004
Pubmed	Hrs, a FYVE finger protein localized to early endosomes, is implicated in vesicular traffic and required for ventral folding morphogenesis.	GATA4 GATA6 GATA5	5.69e-07	9	67	3	10364163
Pubmed	Deletion of exon 20 of the Familial Dysautonomia gene Ikbkap in mice causes developmental delay, cardiovascular defects, and early embryonic lethality.	GATA4 SRF GATA5	8.12e-07	10	67	3	22046433
Pubmed	Mutations in the Cacnl1a4 calcium channel gene are associated with seizures, cerebellar degeneration, and ataxia in tottering and leaner mutant mice.	CACNA1A JUNB JUND	8.12e-07	10	67	3	9060410
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	HOXA10 TCF4 JUNB JUND HOXB7 GATA4 SRF GATA6 GATA5	1.00e-06	544	67	9	28473536
Pubmed	Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice.	GATA4 GATA6 GATA5	1.12e-06	11	67	3	19889636
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRR12 JUNB JUND EHBP1L1 ZNRF3 MTHFD1L LHPP IRS2 NUP214 LTK RGL2 AHNAK2	1.19e-06	1105	67	12	35748872
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	LMNA SLC16A3 AGFG1 FUS AGPS CPS1 AHNAK2	1.77e-06	298	67	7	30737378
Pubmed	Pax3 and Tbx5 specify whether PDGFRα+ cells assume skeletal or cardiac muscle fate in differentiating embryonic stem cells.	GATA4 GATA6 GATA5	1.93e-06	13	67	3	24677751
Pubmed	Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.	LMNA KRT84 KRT77 FUS FLG2	2.08e-06	107	67	5	32989256
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	LMNA KRT77 CCT4 TMED10 FLG2 VCP AHNAK2	2.40e-06	312	67	7	37120454
Pubmed	The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation.	GATA4 GATA6 GATA5	2.45e-06	14	67	3	12149478
Pubmed	Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair.	GATA4 GATA6 GATA5	3.06e-06	15	67	3	24650916
Pubmed	Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development.	GATA4 SRF GATA6	3.06e-06	15	67	3	19782130
Pubmed	Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice.	GATA4 GATA6 GATA5	3.06e-06	15	67	3	18448675
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	LMNA MTHFD1L KRT77 CCT4 SUZ12 TMED10 AGPS FLG2 HNRNPH3 VCP	3.08e-06	803	67	10	36517590
Pubmed	Isolation of human cDNA clones of jun-related genes, jun-B and jun-D.	JUNB JUND	3.66e-06	2	67	2	2112242
Pubmed	GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.	GATA4 GATA5	3.66e-06	2	67	2	14612389
Pubmed	Involvement of GATA-4/-5 transcription factors in ovarian carcinogenesis.	GATA4 GATA5	3.66e-06	2	67	2	16337738
Pubmed	Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes.	JUNB JUND	3.66e-06	2	67	2	1899335
Pubmed	Probing GATA factor function in mouse Leydig cells via testicular injection of adenoviral vectors.	GATA4 GATA6	3.66e-06	2	67	2	28710293
Pubmed	Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators.	GATA4 SRF	3.66e-06	2	67	2	11003651
Pubmed	Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types.	GATA4 GATA5	3.66e-06	2	67	2	17912029
Pubmed	Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue.	GATA4 GATA6	3.66e-06	2	67	2	12130579
Pubmed	Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.	GATA4 GATA6	3.66e-06	2	67	2	19649254
Pubmed	Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis.	GATA4 GATA6	3.66e-06	2	67	2	33876316
Pubmed	Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor.	GATA4 SRF	3.66e-06	2	67	2	11158291
Pubmed	Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development.	GATA4 GATA6	3.66e-06	2	67	2	28196600
Pubmed	GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm.	GATA4 GATA6	3.66e-06	2	67	2	8660897
Pubmed	GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.	GATA4 GATA5	3.66e-06	2	67	2	19509152
Pubmed	The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.	ALK HNRNPH3	3.66e-06	2	67	2	30946933
Pubmed	Hypermethylation of the GATA gene family in esophageal cancer.	GATA4 GATA5	3.66e-06	2	67	2	16823849
Pubmed	Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas.	GATA4 GATA5	3.66e-06	2	67	2	20222162
Pubmed	Hypermethylation of the GATA genes in lung cancer.	GATA4 GATA5	3.66e-06	2	67	2	15585625
Pubmed	JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.	JUNB JUND	3.66e-06	2	67	2	21393445
Pubmed	Parsing the roles of the transcription factors GATA-4 and GATA-6 in the adult cardiac hypertrophic response.	GATA4 GATA6	3.66e-06	2	67	2	24391969
Pubmed	Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy.	GATA4 GATA6	3.66e-06	2	67	2	31190750
Pubmed	GATA-4 and GATA-6 expression in human ovarian surface epithelial carcinoma.	GATA4 GATA6	3.66e-06	2	67	2	18227727
Pubmed	Differentiation of embryonic stem cells is induced by GATA factors.	GATA4 GATA6	3.66e-06	2	67	2	11937486
Pubmed	The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.	GATA4 GATA6	3.66e-06	2	67	2	11356841
Pubmed	Extra-embryonic endoderm cells derived from ES cells induced by GATA factors acquire the character of XEN cells.	GATA4 GATA6	3.66e-06	2	67	2	17605826
Pubmed	Variants in cardiac GATA genes associated with bicuspid aortic valve.	GATA4 GATA5	3.66e-06	2	67	2	30229885
Pubmed	Transcription factors GATA-4 and GATA-6 during mouse and human adrenocortical development.	GATA4 GATA6	3.66e-06	2	67	2	12530677
Pubmed	Transcription factors GATA-4 and GATA-6, and their potential downstream effectors in ovarian germ cell tumors.	GATA4 GATA6	3.66e-06	2	67	2	16110260
Pubmed	Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.	GATA4 GATA6	3.66e-06	2	67	2	18405344
Pubmed	Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.	LTK ALK	3.66e-06	2	67	2	22079349
Pubmed	GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice.	GATA4 GATA6	3.66e-06	2	67	2	21262227
Pubmed	Loss of GATA-6 and GATA-4 in granulosa cells blocks folliculogenesis, ovulation, and follicle stimulating hormone receptor expression leading to female infertility.	GATA4 GATA6	3.66e-06	2	67	2	22434075
Pubmed	Piceatannol attenuates cardiac hypertrophy in an animal model through regulation of the expression and binding of the transcription factor GATA binding factor 6.	GATA4 GATA6	3.66e-06	2	67	2	24662306
Pubmed	Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary.	GATA4 GATA6	3.66e-06	2	67	2	9231805
Pubmed	Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors.	GATA4 GATA6	3.66e-06	2	67	2	15666845
Pubmed	Gata6 is an important regulator of mouse pancreas development.	GATA4 GATA6 GATA5	3.76e-06	16	67	3	16887115
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	HOXA10 ZNF609 EHBP1L1 LMNA RASA1 SLC16A3 OTUD7A SRF IRS2 FUS HNRNPH3	3.78e-06	1021	67	11	26760575
Pubmed	FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart.	GATA4 GATA6 GATA5	4.56e-06	17	67	3	17274974
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	LMNA ACAT1 AGFG1 CCT4 NUP214 FUS HNRNPH3 VCP	4.69e-06	491	67	8	22623428
Pubmed	Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets.	GATA4 SRF GATA6	5.46e-06	18	67	3	15929941
Pubmed	Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins.	JUNB JUND SRF	5.46e-06	18	67	3	9858769
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HOXA10 PRR12 JUNB JUND ZNF609 LMNA GATA6 FBXO11 NUP214 SUZ12 FUS HNRNPH3	6.04e-06	1294	67	12	30804502
Pubmed	Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo.	GATA4 GATA6 GATA5	6.48e-06	19	67	3	22589735
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	HOXA10 TCF4 JUNB JUND GATA4 GATA6 GATA5 SUZ12 EYA2 TLX1	6.68e-06	877	67	10	20211142
Pubmed	GATA5 interacts with GATA4 and GATA6 in outflow tract development.	GATA4 GATA6 GATA5	7.61e-06	20	67	3	21839733
Pubmed	Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse.	GATA4 GATA6 GATA5	7.61e-06	20	67	3	11245568
Pubmed	Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.	GATA4 GATA6 GATA5	1.03e-05	22	67	3	9136933
Pubmed	Insulin-response epigenetic activation of Egr-1 and JunB genes at the nuclear periphery by A-type lamin-associated pY19-Caveolin-2 in the inner nuclear membrane.	JUNB LMNA	1.10e-05	3	67	2	25753664
Pubmed	Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype.	LMNA FUS	1.10e-05	3	67	2	33661429
Pubmed	Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.	FUS VCP	1.10e-05	3	67	2	31767634
Pubmed	The gene for transcription factor GATA-6 resides on mouse chromosome 18 and is expressed in myocardium and vascular smooth muscle.	GATA4 GATA6	1.10e-05	3	67	2	8812463
Pubmed	GATA4-dependent regulation of the secretory phenotype via MCP-1 underlies lamin A-mediated human mesenchymal stem cell aging.	LMNA GATA4	1.10e-05	3	67	2	29760459
Pubmed	Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy.	GATA4 GATA6	1.10e-05	3	67	2	28381408
Pubmed	The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.	JUNB ALK	1.10e-05	3	67	2	25145835
Pubmed	JunB and JunD regulate human heme oxygenase-1 gene expression in renal epithelial cells.	JUNB JUND	1.10e-05	3	67	2	17204476
Pubmed	Sox7 plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and Gata-6 expression.	GATA4 GATA6	1.10e-05	3	67	2	15542856
Pubmed	GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1.	GATA4 GATA6	1.10e-05	3	67	2	14988427
Pubmed	DNA binding activities of three murine Jun proteins: stimulation by Fos.	JUNB JUND	1.10e-05	3	67	2	3142691
Pubmed	The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.	JUNB ALK	1.10e-05	3	67	2	17690253
Pubmed	GATA4 and GATA6 Knockdown During Luteinization Inhibits Progesterone Production and Gonadotropin Responsiveness in the Corpus Luteum of Female Mice.	GATA4 GATA6	1.10e-05	3	67	2	26510866
Pubmed	Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine.	GATA4 GATA6	1.10e-05	3	67	2	16940177
Pubmed	Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor.	JUNB JUND	1.10e-05	3	67	2	2104845
Pubmed	Novel Roles of GATA4/6 in the Postnatal Heart Identified through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre Recombinase.	GATA4 GATA6	1.10e-05	3	67	2	26023924
Pubmed	MYC is a metastasis gene for non-small-cell lung cancer.	GATA4 GATA6	1.10e-05	3	67	2	19551151
Pubmed	Regulation of P450c17 expression in the early embryo depends on GATA factors.	GATA4 GATA6	1.10e-05	3	67	2	18832096
Pubmed	Cooperative interaction between GATA5 and NF-ATc regulates endothelial-endocardial differentiation of cardiogenic cells.	GATA4 GATA5	1.10e-05	3	67	2	12163407
Pubmed	Increased methylation and decreased expression of homeobox genes TLX1, HOXA10 and DLX5 in human placenta are associated with trophoblast differentiation.	HOXA10 TLX1	1.10e-05	3	67	2	28674422
Pubmed	GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis.	GATA4 GATA6	1.10e-05	3	67	2	16137232
Pubmed	Novel mutations of the SRF gene in Chinese sporadic conotruncal heart defect patients.	GATA4 SRF	1.10e-05	3	67	2	32380971
Interaction	CYLD interactions	ZNF609 LMNA ACAT1 MTHFD1L KRT84 KRT77 CCT4 NUP214 FUS FLG2 HERC4 ALK VCP	3.30e-06	868	65	13	int:CYLD
Interaction	SOCS1 interactions	RASA1 TRIM8 CCT4 IRS2 CPS1 ALK	2.27e-05	177	65	6	int:SOCS1
Interaction	ARID3B interactions	LMNA ZNF330 GATA4 SRF TLX1	3.20e-05	113	65	5	int:ARID3B
Interaction	CDC73 interactions	TCF4 ZNF330 GATA4 CCT4 ACTN3 FUS FLG2 VCP	3.28e-05	386	65	8	int:CDC73
Interaction	METTL3 interactions	LMNA ACAT1 KRT84 CCT4 FUS FLG2 VCP	3.79e-05	287	65	7	int:METTL3
Interaction	WRAP73 interactions	MTHFD1L AGPS PTPN18 HERC4 VCP	4.81e-05	123	65	5	int:WRAP73
Interaction	GATA4 interactions	GATA4 SRF GATA6 SUZ12 FUS TMED10 CPS1 HNRNPH3	5.11e-05	411	65	8	int:GATA4
Interaction	LIG3 interactions	LMNA ZNF330 GATA4 SRF SUZ12 TLX1	5.45e-05	207	65	6	int:LIG3
Interaction	NUP35 interactions	PRR12 JUND ZNF609 LMNA ACAT1 NUP214 SUZ12 FUS	6.35e-05	424	65	8	int:NUP35
Interaction	EMX1 interactions	HOXA10 GATA6 TLX1	7.00e-05	25	65	3	int:EMX1
Interaction	FOSL1 interactions	JUNB JUND SRF FBXO11	7.70e-05	70	65	4	int:FOSL1
Interaction	HSPD1 interactions	LMNA RASA1 ACAT1 MTHFD1L GATA4 SUZ12 FUS EYA2 PTPN18 ALK VCP AHNAK2	9.05e-05	1022	65	12	int:HSPD1
Interaction	HDAC2 interactions	ZNF609 LMNA SLC16A3 GATA4 AGFG1 SUZ12 FUS AGPS CPS1 VCP AHNAK2	9.16e-05	865	65	11	int:HDAC2
Interaction	PIK3R2 interactions	LMNA IRS2 FUS LTK ALK VCP	9.75e-05	230	65	6	int:PIK3R2
Interaction	SMARCA4 interactions	JUNB TENT4B ZNF330 GATA4 SRF SUZ12 FUS VCP	1.15e-04	462	65	8	int:SMARCA4
Interaction	EYA4 interactions	PRR12 TCF4 ZNF609 TRIM8 EYA2 TLX1	1.32e-04	243	65	6	int:EYA4
Interaction	NKX2-5 interactions	SMG1 GATA4 SRF TMED10	1.43e-04	82	65	4	int:NKX2-5
Interaction	RICTOR interactions	LMNA KRT77 SLITRK5 CCT4 NUP214 TMED10 CPS1 FLG2 VCP AHNAK2	1.49e-04	759	65	10	int:RICTOR
Interaction	TSPAN7 interactions	CACNA1A LMNA KPTN	1.49e-04	32	65	3	int:TSPAN7
Interaction	PBX1 interactions	HOXA10 HOXB7 GATA4 TLX1	1.64e-04	85	65	4	int:PBX1
Interaction	KRT6A interactions	TENT4B LMNA KRT84 KRT77 VCP	1.67e-04	160	65	5	int:KRT6A
Interaction	BTRC interactions	ZNF609 RASA1 SLC16A3 ZNRF3 CCT4 SUZ12 FUS FLG2 HNRNPH3 VCP	1.76e-04	775	65	10	int:BTRC
Interaction	KDM6A interactions	GATA4 SRF SUZ12 EYA2 TLX1	1.77e-04	162	65	5	int:KDM6A
Interaction	TLE3 interactions	PRR12 TCF4 JUND ZNF609 EYA2 VCP TLX1	2.04e-04	376	65	7	int:TLE3
Interaction	NBR1 interactions	JUNB ACAT1 MTHFD1L CCT4 FUS TMED10 VCP	2.18e-04	380	65	7	int:NBR1
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATA4 GATA6 GATA5	9.39e-06	15	51	3	82
GeneFamily	Basic leucine zipper proteins\|Jun transcription factor family	JUNB JUND	2.34e-05	3	51	2	1257
GeneFamily	Keratins, type II	KRT84 KRT77	2.62e-03	27	51	2	609
ToppCell	Influenza\|World / Disease, condition lineage and cell class	JUND EHBP1L1 SLC16A3 MEGF9 TRIM8 AGFG1 IRS2	2.14e-08	200	67	7	df996c35907a1c9194b9e2ca30e81f520ca067f0
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND SRF IRS2 FUS EYA2	3.73e-07	186	67	6	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND LMNA IRS2 FUS EYA2	4.09e-07	189	67	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	URO\|World / Disease, Lineage and Cell Type	EHBP1L1 SLC16A3 MEGF9 AGFG1 IRS2 NUP214	4.63e-07	193	67	6	421dc0996c6c973f88e90197b651255ae4dd13a2
ToppCell	myeloid-Monocyte\|myeloid / Lineage, cell class and subclass	JUND EHBP1L1 MEGF9 AGFG1 IRS2 NUP214	5.22e-07	197	67	6	6acf059cee6ba6bdeacc089b090d72336790972a
ToppCell	(0)_Myeloid-(00)_Monocyte\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	JUNB JUND EHBP1L1 MEGF9 AGFG1 IRS2	5.37e-07	198	67	6	9c17589ef0f6583c4c106c06936877fd74c258ce
ToppCell	facs-Limb_Muscle\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXA10 JUNB JUND LMNA ACTN3	9.70e-06	189	67	5	21ec43859d21ffc565acbe36489da1d2d0f9877d
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND LMNA SLC16A3 SRF	9.70e-06	189	67	5	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	11.5-Distal\|11.5 / Age, Tissue, Lineage and Cell class	JUNB JUND HOXB7 GATA6 GATA5	1.05e-05	192	67	5	169b9ee2377beb9e4ad35bc82bb7a3dafe8f05b6
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SMG1 JUNB JUND TENT4B FUS	1.07e-05	193	67	5	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	PBMC-Severe-cDC_5\|Severe / Compartment, Disease Groups and Clusters	SMG1 JUNB JUND TENT4B LMNA	1.10e-05	194	67	5	b903e23eb75733ca516770727097fe74a9f8c1d1
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUNB SLC16A3 MEGF9 IRS2 NUP214	1.10e-05	194	67	5	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	myeloid-CD14+_Monocyte\|myeloid / Lineage and Cell class	JUND MEGF9 AGFG1 IRS2 NUP214	1.13e-05	195	67	5	60fab0c24c827567fb42bbd7eb165bf45178c198
ToppCell	myeloid-Monocyte-CD14+_Monocyte\|myeloid / Lineage, cell class and subclass	JUND MEGF9 AGFG1 IRS2 NUP214	1.13e-05	195	67	5	15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUNB SLC16A3 MEGF9 IRS2 NUP214	1.16e-05	196	67	5	ad193b231ff2f7c72590fab79919c179d5d2f327
ToppCell	3'-GW_trimst-2-LargeIntestine\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA10 JUNB JUND LMNA FUS	1.16e-05	196	67	5	27a216af92100224818c91e298428bee25ab0af8
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	SMG1 JUNB JUND IRS2 FUS	1.19e-05	197	67	5	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA10 JUNB JUND LMNA FUS	1.19e-05	197	67	5	9af431323da6d099459b7360af40e5df998cffbd
ToppCell	facs-Diaphragm-Limb_Muscle-3m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 JUNB LMNA CCT4 FUS	1.19e-05	197	67	5	b0e2ea81308bce289cb7cbea0e27de1d01afeed2
ToppCell	mLN-T_cell-Th17\|T_cell / Region, Cell class and subclass	JUND LMNA IRS2 LTK FLG2	1.21e-05	198	67	5	efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JUNB JUND EHBP1L1 IRS2 NUP214	1.21e-05	198	67	5	a7145565703d0e036d2dcef5dba6d86f200845c9
ToppCell	normal_Lung-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	TCF4 JUNB JUND LMNA EYA2	1.21e-05	198	67	5	fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 LMNA SLC16A3 SLITRK5 ACTN3	1.21e-05	198	67	5	d5e91d1057e71b6a336eec95e44b2e7fe6b2c6ef
ToppCell	COVID-19_Severe-Classical_Monocyte\|COVID-19_Severe / disease group, cell group and cell class	SLC16A3 MEGF9 AGFG1 IRS2 NUP214	1.21e-05	198	67	5	b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8
ToppCell	Transverse-T_cell-Th1\|T_cell / Region, Cell class and subclass	JUNB JUND LMNA IRS2 HNRNPH3	1.24e-05	199	67	5	9271d9d36ffe1c169049d4340258f366916adfaf
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA10 JUNB JUND LMNA FUS	1.24e-05	199	67	5	c007cd51577e31553395ceaed70ad447e5854546
ToppCell	Sepsis-URO-Myeloid-CD14+_Monocyte\|URO / Disease, condition lineage and cell class	SLC16A3 MEGF9 AGFG1 IRS2 NUP214	1.27e-05	200	67	5	209976dbbfc1edbeb3ea128cd0453ec9572f54cb
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SOX11 CCT4 FUS HNRNPH3	5.28e-05	136	67	4	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SOX11 CCT4 FUS HNRNPH3	5.28e-05	136	67	4	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JUNB JUND ZNRF3 CCT4	1.20e-04	168	67	4	b08458164d270d625b8ee390122d1c2ce8c653db
ToppCell	COVID_vent-Lymphocytic-Dendritic-pDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TCF4 SLITRK5 LTK AHNAK2	1.28e-04	171	67	4	779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCell	COVID_vent-Lymphocytic-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TCF4 SLITRK5 LTK AHNAK2	1.28e-04	171	67	4	debbb071d260639b16269c94d172766908325c58
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCF4 JUNB JUND IRS2	1.34e-04	173	67	4	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	Severe-B_naive-8\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCF4 JUNB JUND IRS2	1.37e-04	174	67	4	f3f8c924420f46321bd47e2b97f18c7241541599
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	TCF4 DCHS1 NOVA2 AHNAK2	1.40e-04	175	67	4	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GATA4 GATA6 GATA5 CPS1	1.40e-04	175	67	4	6759d200a133034756de9cdf2d5daceca927aac9
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 JUND FUS HERC4	1.40e-04	175	67	4	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	systemic_lupus_erythematosus-managed\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	JUNB JUND LMNA IRS2	1.43e-04	176	67	4	e406a05345461d23cba21c5444223c937143e96a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND LMNA SLC16A3	1.46e-04	177	67	4	ea2c2d2d7ffd34780882299229ff8614fdd7c79c
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND LMNA SLC16A3	1.46e-04	177	67	4	63b5ebbe505f22091bc7b0db818e01fae5d92bb7
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND TRIM8 FUS	1.49e-04	178	67	4	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A GATA6 ACTN3 NOVA2	1.53e-04	179	67	4	b7281160c84dd053a2981c9c76ea6cc6d2592cd5
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 TCF4 JUNB JUND	1.70e-04	184	67	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SMG1 JUND FBXO11 FUS	1.70e-04	184	67	4	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	droplet-Tongue-Unstain-18m-Epithelial-filiform\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC16A3 KRT84 KRTAP1-4 KRTAP1-5	1.73e-04	185	67	4	e0c9e92e35fb24351f5347a0768e6aab5add8775
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	TCF4 DCHS1 LTK NOVA2	1.73e-04	185	67	4	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	Control-B_memory-0\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUNB JUND LMNA FUS	1.77e-04	186	67	4	80f6f25dbe3c5efe4bc350f5d2eb990c38aab338
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLITRK5 DCHS1 GATA5 ACTN3	1.77e-04	186	67	4	b58db5abdd3e9f0214b198c3cbd09b0b3c321eab
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUND MEGF9 AGFG1 IRS2	1.77e-04	186	67	4	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLITRK5 DCHS1 GATA5 ACTN3	1.77e-04	186	67	4	cd6502bbf9dce318fdbb4965d49df8951e5f795c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A GRIK5 LTK PTPN18	1.77e-04	186	67	4	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LANCL3 JUNB JUND FUS	1.81e-04	187	67	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUND NPHP3 FBXO11 FUS	1.81e-04	187	67	4	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLITRK5 DCHS1 GATA5 ACTN3	1.81e-04	187	67	4	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA10 TCF4 JUNB LMNA	1.81e-04	187	67	4	173f029dcf32af008f517912f6d110a33a9e98cf
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLITRK5 DCHS1 GATA5 ACTN3	1.81e-04	187	67	4	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17\|lymph-node_spleen / Manually curated celltypes from each tissue	JUNB JUND LMNA LTK	1.84e-04	188	67	4	a20521198c6db17589535fb439533329582c9dd2
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUND GNPTAB FBXO11 FUS	1.88e-04	189	67	4	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUND LMNA FBXO11 FUS	1.88e-04	189	67	4	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JUND EHBP1L1 MEGF9 AGFG1	1.88e-04	189	67	4	55aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCell	ILEUM\|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUNB JUND LMNA FBXO11	1.92e-04	190	67	4	4395dbd18c14d491f5066a2ddac438a16b1fd7c3
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TCF4 JUND GNPTAB FUS	1.96e-04	191	67	4	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SOX11 HOXB7 DCHS1 NOVA2	1.96e-04	191	67	4	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	COVID-19_Mild-MAIT\|COVID-19_Mild / Disease condition and Cell class	JUNB JUND LMNA LTK	1.96e-04	191	67	4	e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCell	facs-Diaphragm\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 JUNB JUND IRS2	2.00e-04	192	67	4	486cbf9791ca619e307e8b18aa70ce22111f4f26
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	JUNB JUND TENT4B CCT4	2.00e-04	192	67	4	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 SLITRK5 AGFG1 VCP	2.04e-04	193	67	4	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	(1)_T_cells-(1)_T_CD4\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	JUNB JUND LMNA IRS2	2.04e-04	193	67	4	788daf1d7c7a26eb052b386a114248772e05c27e
ToppCell	Control-B_naive-13\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUNB JUND IRS2 FUS	2.04e-04	193	67	4	32e53a6473a682cf14b20a399c3686f658298b93
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JUNB LMNA FUS AHNAK2	2.04e-04	193	67	4	739fb2a57772a800a2e94bdd6c71285bb2c162a7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 GATA5 LTK NOVA2	2.04e-04	193	67	4	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	control-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	JUNB SLC16A3 MEGF9 IRS2	2.08e-04	194	67	4	c2ae2ea848d78725455dcb6be9f1d8933745fa80
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SOX11 TCF4 NOVA2 TLX1	2.08e-04	194	67	4	b111d10c99d7ff7eb261cd7786cd9d9a549049b1
ToppCell	10x3'2.3\|World / cell types per 3 fetal stages;per 3',per 5'	JUNB JUND IRS2 FUS	2.08e-04	194	67	4	fc7ed8350ffe1475b8934dfbb107b51991876b0b
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUND MEGF9 IRS2 NUP214	2.12e-04	195	67	4	ae98215b7b7f22f1aca690920ce6092dc4a3c7db
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A SLC16A3 CPS1 FLG2	2.12e-04	195	67	4	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 GATA5 LTK NOVA2	2.12e-04	195	67	4	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	JUNB JUND LMNA LTK	2.12e-04	195	67	4	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUNB JUND SLC16A3 MEGF9	2.12e-04	195	67	4	b0dbaae86f5703ab62f925e0f36500274044884a
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A SLC16A3 CPS1 FLG2	2.12e-04	195	67	4	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JUND MEGF9 IRS2 NUP214	2.12e-04	195	67	4	6fcab7aa4db958ccad0300adea9aaae52ace5bff
ToppCell	mild_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	JUNB JUND LMNA LTK	2.12e-04	195	67	4	74f0f709d9b3eed5d7e02a51884f02cc281782f1
ToppCell	Mild/Remission-B_naive-8\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCF4 JUNB JUND IRS2	2.12e-04	195	67	4	0a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell	mild_COVID-19\|World / disease group, cell group and cell class (v2)	JUNB JUND LMNA FUS	2.12e-04	195	67	4	6dbe9db5f0e94f2e91b3d1282855d200051ab0ba
ToppCell	normal_Lymph_Node-T/NK_cells-CD4+_Th\|T/NK_cells / Location, Cell class and cell subclass	JUNB JUND LMNA IRS2	2.12e-04	195	67	4	5de6841fa04f6fe6f0c2aa6c300667a25ae6d52e
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	JUNB JUND MEGF9 IRS2	2.12e-04	195	67	4	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	PBMC-Control-cDC_7\|Control / Compartment, Disease Groups and Clusters	JUNB JUND TENT4B LMNA	2.12e-04	195	67	4	c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 GATA5 LTK NOVA2	2.16e-04	196	67	4	d323f7dc41380446e5967c69832bea88351a9331
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA10 TCF4 JUNB LMNA	2.16e-04	196	67	4	a7adc0e0baef261d0937e4e8351321d41beca82f
ToppCell	Influenza_Severe\|World / Disease group and Cell class	SLC16A3 MEGF9 AGFG1 IRS2	2.16e-04	196	67	4	6a8ecb524f55212a91060d45ab8612f3f677e543
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TCF4 DCHS1 GATA6 NOVA2	2.16e-04	196	67	4	915e4a7422058be246b54760df31e8a607310625
ToppCell	control-Others-Megakaryocytes\|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	JUNB SLC16A3 MEGF9 IRS2	2.16e-04	196	67	4	10d914f1612622f64ac71da04e1995a854a4bec9
ToppCell	mild-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	JUNB MEGF9 IRS2 SLC45A4	2.16e-04	196	67	4	9c351306b6aae68ed47d4cb1911957bf67f9e1ae
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SMG1 JUNB FUS TMED10	2.16e-04	196	67	4	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	(7)_MNP-(7)_Monocyte\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SLC16A3 MEGF9 AGFG1 NUP214	2.16e-04	196	67	4	4c2ea16352ba3482c02c03866460e0d975f9fc99
ToppCell	mild-Myeloid-Neutrophils_4\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	JUNB MEGF9 IRS2 SLC45A4	2.16e-04	196	67	4	f8c98cded5550843322b1711e1a57c7e88cae861
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUNB JUND IRS2 FUS	2.16e-04	196	67	4	9a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell	(0)_Myeloid-(000)_CD14+_Monocyte\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	JUNB JUND MEGF9 IRS2	2.16e-04	196	67	4	e9718642ee2751c9d46a1b968547bdcb59cdfd30
ToppCell	Mesenchymal_cells-Myofibroblasts\|World / Lineage and Cell class	SOX11 JUND LMNA ACTN3	2.16e-04	196	67	4	2c0f429ae18c2df05c33ddf58dcc2c94b819b9a1
ToppCell	(000)_CD14+_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	SLC16A3 MEGF9 IRS2 NUP214	2.20e-04	197	67	4	cff498bc7b153f28dd013eaeb73ead4fb62fb44c
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	LZTS3 SLC16A3 SRF IRS2 GRIK5 FUS HERC4	1.44e-06	190	67	7	4362_DN
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A	CACNA1A EHBP1L1 SRF SLITRK5 GRIK5 CPS1 KPTN	1.83e-06	197	67	7	2350_UP
Drug	Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A	JUNB LMNA MEGF9 CPS1 HERC4 ALK NOVA2	1.89e-06	198	67	7	7313_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	HOXA10 JUND ZNF609 LMNA SRF PTPN18	2.16e-05	192	67	6	4450_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	HOXA10 GATA4 LHPP FBXO11 GRIK5 HERC4	2.16e-05	192	67	6	6435_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	ZNF609 SLC16A3 SRF GRIK5 NUP214 ALK	2.36e-05	195	67	6	4384_DN
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	JUNB JUND MEGF9 NUP214 PTPN18 HERC4	2.50e-05	197	67	6	3561_DN
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; HL60; HT_HG-U133A	HOXA10 ZNF609 EHBP1L1 LMNA SLITRK5 GRIK5	2.50e-05	197	67	6	2362_UP
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	HOXA10 HOXB7 LMNA GRIK5 EYA2 NOVA2	2.57e-05	198	67	6	3059_UP
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; PC3; HT_HG-U133A	JUND GATA4 LHPP NUP214 PTPN18 KPTN	2.57e-05	198	67	6	6730_DN
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	HOXA10 JUNB EHBP1L1 LMNA IRS2 GRIK5	2.57e-05	198	67	6	6267_UP
Drug	Cosopt	JUNB JUND GATA4 SRF GATA6 GATA5 FUS	6.40e-05	341	67	7	CID000003154
Drug	AC1O5LBK	JUNB JUND GATA4 SRF GATA6 GATA5	7.87e-05	242	67	6	CID006436256
Drug	NSC648766	JUNB CCT4 FUS VCP	1.64e-04	93	67	4	CID000003199
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; PC3; HG-U133A	JUNB JUND ZNF609 IRS2 PTPN18	1.90e-04	180	67	5	1937_UP
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A	HOXA10 EHBP1L1 MEGF9 SLITRK5 PTPN18	2.27e-04	187	67	5	6764_DN
Drug	1,2-diaminopropane	CACNA1A SRF	2.36e-04	8	67	2	CID000006567
Drug	ginsenoside Rb1	GATA4 CCT4 NUP214	2.40e-04	41	67	3	CID000073148
Drug	Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A	TCF4 LZTS3 SLC16A3 SLITRK5 PTPN18	2.44e-04	190	67	5	2189_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A	ZNF609 SLC16A3 AGFG1 FUS VCP	2.44e-04	190	67	5	1974_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A	JUND ZNF609 FUS PTPN18 HERC4	2.56e-04	192	67	5	4334_DN
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 SLC16A3 SLITRK5 AGFG1 HNRNPH3	2.62e-04	193	67	5	6920_UP
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	JUND GNPTAB IRS2 NUP214 HERC4	2.68e-04	194	67	5	2863_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 LMNA IRS2 AHNAK2	2.68e-04	194	67	5	3861_DN
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A	SLITRK5 FBXO11 FUS PTPN18 HERC4	2.68e-04	194	67	5	4221_DN
Drug	Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 GNPTAB GATA4 RAB40C	2.68e-04	194	67	5	6081_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	SRF IRS2 GRIK5 PTPN18 NOVA2	2.68e-04	194	67	5	3679_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	LZTS3 SLC16A3 GNPTAB CPS1 ALK	2.68e-04	194	67	5	5278_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	JUND ZNF609 LZTS3 SLC16A3 FUS	2.68e-04	194	67	5	3840_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	TCF4 ZNF609 FBXO11 HERC4 KPTN	2.75e-04	195	67	5	4220_DN
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A	JUNB JUND GATA4 LHPP PTPN18	2.75e-04	195	67	5	6739_DN
Drug	aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A	JUND ZNF609 SRF SLITRK5 IRS2	2.75e-04	195	67	5	4428_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	JUND ZNF609 MEGF9 SRF ALK	2.75e-04	195	67	5	3737_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	GATA4 RAB40C GRIK5 NUP214 CPS1	2.75e-04	195	67	5	4345_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ZNF609 LZTS3 GATA4 FBXO11 GRIK5	2.75e-04	195	67	5	2230_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	TCF4 SLITRK5 HERC4 HNRNPH3 KPTN	2.75e-04	195	67	5	3710_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 SRF FBXO11 CPS1	2.75e-04	195	67	5	6808_UP
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 LZTS3 IRS2 NOVA2	2.75e-04	195	67	5	7468_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; HL60; HT_HG-U133A	CACNA1A ZNF609 LMNA LZTS3 SLC16A3	2.75e-04	195	67	5	2432_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	TCF4 ZNF609 SLC16A3 MEGF9 FBXO11	2.75e-04	195	67	5	6159_DN
Drug	Morantel tartrate [26155-31-7]; Up 200; 10.8uM; HL60; HT_HG-U133A	CACNA1A LZTS3 SRF SLITRK5 KPTN	2.81e-04	196	67	5	1840_UP
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ZNF609 SLC16A3 IRS2 GRIK5 NUP214	2.81e-04	196	67	5	2258_DN
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HT_HG-U133A	TCF4 ZNF609 SLC16A3 ZNF330 NUP214	2.81e-04	196	67	5	4656_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; MCF7; HT_HG-U133A	EHBP1L1 SLC16A3 MEGF9 FBXO11 IRS2	2.81e-04	196	67	5	7027_UP
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A	EHBP1L1 SLC16A3 ZNF330 CPS1 ALK	2.81e-04	196	67	5	2377_DN
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A	EHBP1L1 LZTS3 IRS2 NUP214 CPS1	2.81e-04	196	67	5	1497_UP
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HOXA10 ZNF609 EHBP1L1 LMNA HNRNPH3	2.81e-04	196	67	5	2818_DN
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	TCF4 ZNF609 EHBP1L1 MEGF9 PTPN18	2.81e-04	196	67	5	5767_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	SLC16A3 SRF NUP214 FUS HERC4	2.81e-04	196	67	5	3847_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	JUND MEGF9 SRF CPS1 ALK	2.81e-04	196	67	5	3783_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	LZTS3 SLC16A3 MEGF9 FUS HERC4	2.81e-04	196	67	5	3842_DN
Drug	Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	SLC16A3 GNPTAB RAB40C FUS HERC4	2.81e-04	196	67	5	3837_UP
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A	HOXA10 JUNB SLC16A3 CPS1 ALK	2.81e-04	196	67	5	2373_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	LMNA SLC16A3 MEGF9 LHPP PTPN18	2.81e-04	196	67	5	3251_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; HL60; HT_HG-U133A	JUNB MEGF9 FUS HERC4 ALK	2.81e-04	196	67	5	2372_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	JUND ZNF609 EHBP1L1 GATA4 SLITRK5	2.81e-04	196	67	5	5807_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; HL60; HT_HG-U133A	HOXA10 ZNF609 LMNA SLC16A3 SLITRK5	2.81e-04	196	67	5	3025_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A	SLC16A3 MEGF9 IRS2 GRIK5 FUS	2.81e-04	196	67	5	2648_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	JUND ZNF609 SRF SLITRK5 PTPN18	2.88e-04	197	67	5	4461_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; PC3; HT_HG-U133A	JUNB ZNF330 FUS AGPS PTPN18	2.88e-04	197	67	5	6327_DN
Drug	Altretamine [654-05-6]; Up 200; 19uM; PC3; HT_HG-U133A	TCF4 SRF GRIK5 NUP214 HERC4	2.88e-04	197	67	5	4627_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A	JUND LMNA LHPP PTPN18 ALK	2.88e-04	197	67	5	2122_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF330 AGFG1 FBXO11 FUS HERC4	2.88e-04	197	67	5	5344_DN
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; HL60; HT_HG-U133A	TCF4 LMNA LZTS3 SLC16A3 PTPN18	2.88e-04	197	67	5	2150_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CACNA1A LZTS3 RAB40C GRIK5 AHNAK2	2.88e-04	197	67	5	3930_DN
Drug	Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A	JUND EHBP1L1 RAB40C IRS2 NOVA2	2.88e-04	197	67	5	7476_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; PC3; HT_HG-U133A	ZNF609 GNPTAB SLITRK5 LHPP CPS1	2.88e-04	197	67	5	5791_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A	TCF4 ZNF609 LZTS3 GRIK5 NUP214	2.88e-04	197	67	5	4715_UP
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	LZTS3 SLC16A3 FBXO11 IRS2 FUS	2.88e-04	197	67	5	5274_DN
Drug	felodipine; Up 200; 10uM; MCF7; HG-U133A	CACNA1A JUND DCHS1 LHPP ALK	2.88e-04	197	67	5	337_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	GNPTAB AGFG1 FUS EYA2 HERC4	2.88e-04	197	67	5	1075_DN
Drug	3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A	HOXA10 GNPTAB GRIK5 LTK NOVA2	2.88e-04	197	67	5	3382_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 LMNA SRF AHNAK2	2.88e-04	197	67	5	3877_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EHBP1L1 LZTS3 LHPP CPS1 HERC4	2.88e-04	197	67	5	3924_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A	EHBP1L1 LZTS3 RAB40C NUP214 NOVA2	2.88e-04	197	67	5	7482_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	HOXA10 ZNF609 NUP214 NOVA2 AHNAK2	2.95e-04	198	67	5	6503_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	HOXA10 TCF4 ZNF609 IRS2 CPS1	2.95e-04	198	67	5	5443_UP
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	CACNA1A ZNF609 FBXO11 IRS2 CPS1	2.95e-04	198	67	5	4584_DN
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	SLC16A3 LHPP EYA2 PTPN18 HERC4	2.95e-04	198	67	5	7416_DN
Drug	Trimethadione [127-48-0]; Down 200; 28uM; HL60; HT_HG-U133A	TCF4 ZNF609 SLC16A3 GATA6 NUP214	2.95e-04	198	67	5	2486_DN
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A	JUND LMNA SLC16A3 IRS2 HERC4	2.95e-04	198	67	5	6450_DN
Drug	Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A	HOXA10 TCF4 ZNF609 LZTS3 GRIK5	2.95e-04	198	67	5	5672_UP
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	TCF4 ZNF609 LMNA FBXO11 KPTN	2.95e-04	198	67	5	1868_DN
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	HOXA10 LZTS3 HERC4 ALK AHNAK2	2.95e-04	198	67	5	4126_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	EHBP1L1 LZTS3 NUP214 HERC4 NOVA2	2.95e-04	198	67	5	6019_UP
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A	JUNB JUND LMNA SLITRK5 ALK	2.95e-04	198	67	5	2398_DN
Drug	Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HOXB7 SLC16A3 ZNF330 LHPP PTPN18	2.95e-04	198	67	5	6204_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	JUND ZNF609 LMNA SLC16A3 IRS2	2.95e-04	198	67	5	3551_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; PC3; HT_HG-U133A	SLC16A3 DCHS1 LHPP HERC4 NOVA2	2.95e-04	198	67	5	3728_UP
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A	HOXA10 LMNA FBXO11 GRIK5 VCP	3.02e-04	199	67	5	1890_DN
Drug	Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	JUNB LMNA SLC16A3 ZNF330 IRS2	3.02e-04	199	67	5	3558_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A	LMNA SRF FBXO11 GRIK5 PTPN18	3.02e-04	199	67	5	4438_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; HL60; HG-U133A	RASA1 TRIM8 AGFG1 FBXO11 TMED10	3.02e-04	199	67	5	1387_DN
Drug	Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A	HOXA10 TCF4 SRF HERC4 AHNAK2	3.02e-04	199	67	5	4777_UP
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	JUND ZNF609 SLC16A3 MEGF9 EYA2	3.02e-04	199	67	5	1467_DN
Drug	Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A	JUND SRF LHPP GRIK5 ACTN3	3.02e-04	199	67	5	4485_UP
Drug	17-AAG; Down 200; 1uM; PC3; HG-U133A	HOXA10 HOXB7 SRF LHPP GRIK5	3.02e-04	199	67	5	450_DN
Drug	IBI-C83	JUNB JUND	3.03e-04	9	67	2	CID000068764
Drug	2-oxothiazolidine-4-carboxylic acid	JUNB JUND	3.03e-04	9	67	2	ctd:C029536
Drug	iododimethylarsine	JUNB JUND	3.03e-04	9	67	2	CID000069608
Disease	tetralogy of Fallot (is_implicated_in)	GATA4 GATA6 GATA5	2.61e-06	13	63	3	DOID:6419 (is_implicated_in)
Disease	ventricular septal defect (is_implicated_in)	GATA4 GATA6 GATA5	3.32e-06	14	63	3	DOID:1657 (is_implicated_in)
Disease	Tetralogy of Fallot	GATA4 GATA6 GATA5	5.09e-06	16	63	3	C0039685
Disease	ATRIOVENTRICULAR CANAL DEFECT	GATA4 GATA6	1.34e-05	3	63	2	C1389016
Disease	Atrioventricular Septal Defect	GATA4 GATA6	1.34e-05	3	63	2	C1389018
Disease	atrioventricular septal defect (is_implicated_in)	GATA4 GATA6	1.34e-05	3	63	2	DOID:0050651 (is_implicated_in)
Disease	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	GATA4 GATA6 GATA5	1.39e-05	22	63	3	C1843687
Disease	Familial atrioventricular septal defect	GATA4 GATA6	2.68e-05	4	63	2	cv:CN029142
Disease	Partial atrioventricular canal	GATA4 GATA6	2.68e-05	4	63	2	C0344735
Disease	neuroblastoma (implicated_via_orthology)	LTK ALK	4.47e-05	5	63	2	DOID:769 (implicated_via_orthology)
Disease	renal carcinoma (biomarker_via_orthology)	JUNB JUND	4.47e-05	5	63	2	DOID:4451 (biomarker_via_orthology)
Disease	Tetralogy of Fallot	GATA4 GATA6	6.69e-05	6	63	2	cv:C0039685
Disease	TETRALOGY OF FALLOT	GATA4 GATA6	6.69e-05	6	63	2	187500
Disease	amino acid measurement, threonine measurement	CCT4 CPS1	9.36e-05	7	63	2	EFO_0005134, EFO_0009775
Disease	Frontotemporal Dementia With Motor Neuron Disease	FUS VCP	1.25e-04	8	63	2	C3888102
Disease	chronic central serous retinopathy	MEGF9 GATA5	1.60e-04	9	63	2	EFO_0009363
Disease	Ostium secundum atrial septal defect	GATA4 GATA6	1.60e-04	9	63	2	C0344724
Disease	chronic kidney disease, Proteinuria	CACNA1A SLC16A3	2.44e-04	11	63	2	EFO_0003884, HP_0000093
Disease	frontotemporal dementia (implicated_via_orthology)	FUS VCP	2.92e-04	12	63	2	DOID:9255 (implicated_via_orthology)
Disease	Monogenic diabetes	LMNA GATA6	5.28e-04	16	63	2	C3888631
Disease	Amyotrophic lateral sclerosis	FUS VCP	5.98e-04	17	63	2	cv:C0002736
Disease	smoking behavior, BMI-adjusted waist-hip ratio	JUND ZNRF3 EYA2	8.37e-04	86	63	3	EFO_0004318, EFO_0007788
Disease	Congenital diaphragmatic hernia	GATA4 GATA6	9.18e-04	21	63	2	C0235833
Disease	Adenocarcinoma of lung (disorder)	JUNB LMNA RASA1 ALK	9.96e-04	206	63	4	C0152013
Disease	otitis media (implicated_via_orthology)	LMNA FBXO11	1.01e-03	22	63	2	DOID:10754 (implicated_via_orthology)
Disease	albuminuria	TCF4 LTK CPS1	1.08e-03	94	63	3	EFO_0004285
Disease	cortical thickness change measurement, age at assessment	SORCS2 GRIK5	1.10e-03	23	63	2	EFO_0008007, EFO_0021501
Disease	congenital heart disease (is_implicated_in)	GATA4 GATA6	1.20e-03	24	63	2	DOID:1682 (is_implicated_in)
Disease	aspartate measurement	GNPTAB CPS1	1.20e-03	24	63	2	EFO_0010462
Disease	Seizures	TCF4 ACAT1 TRIM8 KPTN	1.23e-03	218	63	4	C0036572
Disease	Neonatal diabetes mellitus	GATA4 GATA6	1.30e-03	25	63	2	C0158981
Disease	ergothioneine measurement	CACNA1A CPS1	1.41e-03	26	63	2	EFO_0021163
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	JUND ZNRF3 EYA2	1.49e-03	105	63	3	EFO_0007788, EFO_0008007, EFO_0008343
Disease	fibrinogen measurement	PRR12 GRIK5 CPS1	1.66e-03	109	63	3	EFO_0004623
Disease	Epileptic encephalopathy	CACNA1A NUP214	1.88e-03	30	63	2	C0543888
Disease	temporal lobe epilepsy (biomarker_via_orthology)	CACNA1A GRIK5	2.00e-03	31	63	2	DOID:3328 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
YEDVAGGAQTGGLGF	PTPN18	426	Q99952
RYGGGGSGAAAGVVV	CACNA1A	11	O00555
FGVKGGAAGGGYAQV	MTHFD1L	461	Q6UB35
RGDSGAYDGSGACGG	MKRN4P	61	Q13434
YSLASGAGGGGSKGN	RAB40C	241	Q96S21
AGAGGGGAAAGSSAY	RASA1	16	P20936
AGRYAAAGAGGGGGV	CFAP99	651	D6REC4
AGGGRADGGGVVYSG	TENT4B	91	Q8NDF8
GTQGYALSGDGAGET	DCHS1	176	Q96JQ0
GQYGSGSGQSTGLGQ	FLG2	1206	Q5D862
SCVGLGFGAGSGIGY	KRT84	101	Q9NSB2
YRSVGGSGGGSFGDN	LMNA	626	P02545
GGSSGGGSGYQDLGT	LZTS3	261	O60299
NSGGSRYIAGGGGTG	GNPTAB	471	Q3T906
GLADLAGSTAGDYGG	SLC16A3	306	O15427
GGGGGNYGQDQSSMS	FUS	171	P35637
SGGGSGGGYGNQDQS	FUS	186	P35637
GGGYGNQDQSGGGGS	FUS	191	P35637
GGLGSGYGTGLLSAN	TCF4	431	P15884
YGDEALSGLGGGASG	JUND	6	P17535
NLSSYAGGAGGAGGA	JUND	196	P17535
AGGAGGAGGAATVAF	JUND	201	P17535
GGGGGYRGGDASETD	LTK	326	P29376
SNVYGLAGGAGGRGE	KPTN	26	Q9Y664
GGVFTFGAGGYGQLG	HERC4	261	Q5GLZ8
IYSFGLGGNGQLGTG	HERC4	316	Q5GLZ8
LEGGGGAGTYRVGSA	EHBP1L1	1151	Q8N3D4
AGASACQGGLYGGVA	LANCL3	56	Q6ZV70
ASAGNVTGGGGAAGQ	MEGF9	36	Q9H1U4
GFGQGGSVFGGTSAA	NUP214	1811	P35658
MGGHGYGGAGDASSG	HNRNPH3	176	P31942
GRDGMDNQGGYGSVG	HNRNPH3	286	P31942
GTGCGIGGGIGYGQE	KRTAP1-4	36	P0C5Y4
GIGGGISYGQEGSSG	KRTAP1-5	96	Q9BYS1
VLYDSGAGGGTAIAG	LHPP	21	Q9H008
GTAKGYGSGGGGAQQ	HOXA10	221	P31260
GGTGGGVDNSEDPVY	OTUD7A	286	Q8TE49
AANGYLGAGAGGGAG	NOVA2	361	Q9UNW9
GGGGMAGQSAAGVYA	HOXB7	61	P09629
LGGSAGAAGAEDSYG	IRS2	171	Q9Y4H2
LSYLQGGGAGSASGG	GATA4	51	P43694
AYSSGGGAAGAGLAG	GATA4	131	P43694
GGAAGAGLAGREQYG	GATA4	136	P43694
GSAGGRDGSAYQGAL	GATA5	106	Q9BWX5
GYAAAGSGGAGGVSG	GATA6	281	Q92908
GGLSIGQAGEFDYSG	CPS1	431	P31327
GNQGGVYIFGDGRGL	FBXO11	546	Q86XK2
SNGKLYSAGAGGDAG	GRIK5	886	Q16478
YSAGAGGDAGSAHGG	GRIK5	891	Q16478
TGFYQGGNGLGNAAG	EYA2	141	O00167
GAGKAAQSGDYGGAG	SOX11	181	P35716
QTGYAAGKGVGGGSA	RGL2	191	O15211
GGAEEASGGTGYGGE	RGL2	626	O15211
AGGEVIEDTYGAGGG	NPHP3	11	Q7Z494
TAGGEAGFAGAVYGG	SMG1	2426	Q96Q15
AGFAGAVYGGGGQQA	SMG1	2431	Q96Q15
DTGTGAEQLGGGGGY	SORCS2	1066	Q96PQ0
ATAGAAGGRGKGAYQ	CCT4	11	P50991
EYGLASICNGGGGAS	ACAT1	406	P24752
TGKGGYGAAAGGATR	PRR12	391	Q9ULL5
AYATGKASGAGGAGG	PRR12	426	Q9ULL5
VGGPEASAAATGGYG	SRF	111	P11831
GGGGGGYIGGNAASN	ALK	931	Q9UM73
AGASGYSVTGGGDQG	AHNAK2	121	Q8IVF2
RFAGGGGGGEYMEQE	ACTN3	16	Q08043
AAAGGTGLGAGASYG	AGPS	6	O00116
IFSAGQGGDQGSGFG	AGFG1	336	P52594
FSAGLGGAIGYVLGG	SLC45A4	201	Q5BKX6
NMQYSVYGGGGGTGG	SLITRK5	711	O94991
GSGGGTGGSVYTEDN	VCP	786	P55072
GAYEISDQSGGAGGL	TMED10	56	P49755
GGGGFGGSAAVAAAT	SUZ12	21	Q15022
LGGRGGQYDGSAGVD	ZNF609	191	O15014
GSAAATGAGGAGAYG	TLX1	61	P31314
QVARGGGGGSGCYTE	ZNRF3	786	Q9ULT6
GRQTGGEEGDGASGY	ZNF330	236	Q9Y3S2
VGGQYGAAGTASGEG	TRIM8	396	Q9BZR9
EGGGGGSYFSGQGSD	JUNB	61	P17275
GSGGGSPAVGSVCYA	KRT77	26	Q7Z794